Annals of Hematology

, Volume 92, Issue 7, pp 999–1000 | Cite as

Factor VIII haplotypes in severe hemophilia A patients in India

Letter to the Editor



The authors wish to thank the Lady Tata Memorial Trust, Mumbai, for the Junior Research Scholarship awarded to one of the authors (PP).

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Ghosh K, Shetty S, Kulkarni B, Nair S, Pawar A, Khare A, Baindur S, Mohanty D (2001) Development of inhibitors in patients with haemophilia from India. Haemophilia 7:273–278PubMedCrossRefGoogle Scholar
  2. 2.
    Ghosh K, Jijina F, Shetty S, Madkaikar M, Mohanty D (2002) First-time development of FVIII inhibitor in haemophilia patients during the postoperative period. Haemophilia 8:776–780PubMedCrossRefGoogle Scholar
  3. 3.
    Ghosh K, Shetty S (2009) Immune response to FVIII in hemophilia A: an overview of risk factors. Clinic Rev Allergy Immunol 37:58–66CrossRefGoogle Scholar
  4. 4.
    Viel K, Ameri A, Abshire TC, Iyer RV, Watts RG, Lutcher C, Channell C, Cole SA, Fernstrom KM, Nakaya S, Kasper CK, Thompson AR, Almasy L, Howard TE (2009) Inhibitors of factor VIII in black patients with hemophilia. N Engl J Med 360:1618–1627PubMedCrossRefGoogle Scholar
  5. 5.
    Inaba H, Shinozawa K, Hagiwara T, Suzuki T, Yamamoto Y, Amano K, Fukutake K (2012) Factor VIII haplotypes of Japanese population show similarity to those of Caucasian populations. Haemophilia 18:e43–e44. doi:10.1111/j.1365-2516.2011.02715.x PubMedCrossRefGoogle Scholar
  6. 6.
    Elmahmoudi H, Belhedi N, Jlizi A, Zahra K, Meddeb B, Elgaaied ABA, Gouider E (2011) Factor VIII haplotypes frequencies in Tunisian hemophiliacs A. Diagn Pathol 6:54PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Patricia Pinto
    • 1
  • Kanjaksha Ghosh
    • 1
  • Shrimati Shetty
    • 1
  1. 1.National Institute of Immunohaematology (ICMR)MumbaiIndia

Personalised recommendations